Shire Faces Another Challenge To Patent For Adderall XR
Colony Pharmaceuticals Inc. has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) for a generic version of Shire's amphetamine Adderall XR, Shide said.
Adderall is indicated as an integral part of a total treatment program, which typically includes other measures) for patients with the syndrome. The patents protecting Adderall...
To view the full article, register now.